Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

Bright Minds Biosciences Appoints New Board Member and Expands Leadership Team

Additions of industry veterans, Dr. Emer Leahy to the Board of Directors and Dr. Tom Lategan as Vice President of Regulatory Affairs, position the Company to advance drug development programsVANCOUVER, British Columbia, June 14, 2021 -- Bright Minds Biosciences (โ€œBright Minds,โ€ โ€œBMBโ€ or the โ€œCompanyโ€) (CSE:DRUG) (OTCQB:BMBIF), a biotechno... Read More...

Bright Minds Biosciences Announces Application to List on Nasdaq

VANCOUVER, British Columbia, June 16, 2021 -- Bright Minds Biosciences (โ€œBright Minds,โ€ โ€œBMBโ€ or the โ€œCompanyโ€) (CSE: DRUG) (OTCQB: BMBIF), a biotechnology company focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy, and pain, is pleased to announce that it has submitted an application to list on ... Read More...